AVGO vs DXC
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Broadcom exhibits a dichotomy between elite operational performance and poor deterministic value metrics. While the Piotroski F-Score of 4/9 indicates stable health, the stock trades at a massive premium to its Graham Number ($44.08) and Intrinsic Value ($151.04). This valuation gap is partially justified by a very attractive PEG ratio (0.68) and strong forward P/E (19.65), suggesting high growth expectations. However, aggressive insider selling by the CEO and CFO, combined with a bearish technical trend, offsets the strong analyst 'strong_buy' consensus.
DXC presents a classic 'value trap' profile, characterized by a stable Piotroski F-Score of 4/9 and a massive valuation disconnect where the current price ($11.88) sits far below the Graham Number ($30.94) and Intrinsic Value ($67.85). While the company shows impressive earnings growth (96.8% YoY) and consistent quarterly beats, this is offset by stagnant to declining revenue growth (-1.00%) and a devastating long-term price trend (-62.5% over 5 years). The extreme low P/E (5.17) and P/B (0.64) suggest deep value, but the 0/100 technical trend and bearish insider sentiment indicate a lack of market confidence in a turnaround.
Compare Another Pair
Related Comparisons
AVGO vs DXC: Head-to-Head Comparison
This page compares Broadcom Inc. (AVGO) and DXC Technology Company (DXC) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.